Literature DB >> 7676711

Twelve-year experience with the long intestinal tube.

R Rodriguez-Ruesga1, A P Meagher, B G Wolff.   

Abstract

A number of surgical methods, including use of the long intestinal tube, have been designed to decrease the incidence of recurrent small bowel obstruction. The aim of the present study was to review the indications, morbidity, and long-term results of the long intestinal tube at the Mayo Clinic. During the 12-year period 1981-1992, 47 patients had such tubes placed. The patients formed a complex surgical group: 46 patients had previously undergone at least one laparotomy (median 4, range 1-10); 41 patients had been hospitalized at least once for small bowel obstruction (median 3, range 1-15); and all 41 of these patients had undergone at least one previous laparotomy for obstruction (median 2, range 1-7). Eleven patients had a history of inflammatory bowel disease, and eight had a history of irradiation. In addition to dense adhesions in 46 patients, operative findings included large bowel tumors in six patients, intraperitoneal carcinomatosis in four, intraabdominal abscess in four, and small bowel stricture in three. Twenty patients required either a small bowel or large bowel resection, and three had a stoma fashioned. Only one case of morbidity (tube retraction) was related to tube placement. Among the 36 patients with complete follow-up, nine patients developed episodes of recurrent adhesional small bowel obstruction after a mean follow-up of 48 months, although only one required laparotomy. Of the remaining 11 patients it is known that two developed small bowel obstruction, one of whom required laparotomy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7676711     DOI: 10.1007/bf00294740

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

1.  Complete surgical decompression for late obstruction of the small intestine, with reference to a method.

Authors:  J W BAKER; K J RITTER
Journal:  Ann Surg       Date:  1963-05       Impact factor: 12.969

2.  Experience with intestinal plication and a proposed modification.

Authors:  W A CHILDS; R B PHILLIPS
Journal:  Ann Surg       Date:  1960-08       Impact factor: 12.969

3.  Baker tube jejunostomy. Management of small bowel obstruction.

Authors:  R K Markee; B E Uhlig
Journal:  Minn Med       Date:  1971-12

4.  Treatment of complicated intestinal obstructions by use of the Baker tube.

Authors:  A Behrend; M C Piezas
Journal:  Int Surg       Date:  1969-07

Review 5.  Recurrent adhesive small bowel obstruction.

Authors:  P F Jones; A Munro
Journal:  World J Surg       Date:  1985-12       Impact factor: 3.352

6.  Long-tube gastrostomy with internal intestinal splinting: ten-year experience.

Authors:  R D Robbins; S R Hayes; G B Thow
Journal:  Dis Colon Rectum       Date:  1980 Jan-Feb       Impact factor: 4.585

7.  Complications associated with the Baker tube jejunostomy.

Authors:  C P Chilimindris; G L Stonesifer
Journal:  Am Surg       Date:  1978-11       Impact factor: 0.688

8.  Intestinal polyposis: the present position.

Authors:  H E Lockhart-Mummery
Journal:  Proc R Soc Med       Date:  1967-04

9.  Intraluminal Miller-Abbott tube stenting as treatment and prophylaxis of recurrent intestinal obstruction.

Authors:  C H Wittens; J D Munting; J Lens
Journal:  Neth J Surg       Date:  1990-10

10.  Bowel obstruction and the long tube stent.

Authors:  N L Brightwell; A S McFee; J B Aust
Journal:  Arch Surg       Date:  1977-04
View more
  2 in total

1.  Intraluminal stenting in the management of adhesional intestinal obstruction.

Authors:  D J DeFriend; O E Klimack; C S Humphrey; I G Schraibman
Journal:  J R Soc Med       Date:  1997-03       Impact factor: 5.344

2.  Long intestinal tube splinting prevents postoperative adhesive small-bowel obstruction in sclerosing encapsulating peritonitis.

Authors:  Min Li; Weiming Zhu; Yousheng Li; Jun Jiang; Jieshou Li; Ning Li
Journal:  BMC Gastroenterol       Date:  2014-11-25       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.